News Releases

Scientists Discover How Remdesivir Works to Inhibit Coronavirus

Jan 28, 2021 Remdesivir is the only antiviral drug approved for use in the U.S.…

A protein that can melt tumors discovered at Vanderbilt

by Marissa Shapiro Jan. 27, 2021, 9:00 AMFor the second time, cancer researchers at Vanderbilt have discovered…

Monell Center Receives Kleberg Foundation Grant to Discriminate Bacterial and Viral Immune Responses to Reduce Antibiotic Use

PHILADELPHIA, January 18, 2021 – According to the Centers for Disease Control, nearly three million…

UTMB researchers find Pfizer vaccine effective against new COVID-19 strain

GALVESTON, Texas –A collaborative team from The University of Texas Medical Branch at Galveston and Pfizer has shown…

Drinking blocks a chemical that promotes attention Norepinephrine release to cells is diminished, causing cascade of effects

SAN ANTONIO, Texas, USA - In a new paper, researchers from The University of Texas…

Penn researchers uncover epigenetic drivers for Alzheimer’s disease

The identification of this epigenetic process highlights potential drug treatment strategies for early-stage disease treatment.…

UTMB researchers identify proteins that block immune response to COVID-19

GALVESTON, Texas — Researchers from The University of Texas Medical Branch at Galveston have discovered…

Conversion of Human Cardiac Progenitor Cells into Cardiac Pacemaker-like Cells

AUTHORS:  Suchi Raghunathan1, Jose Francisco Islas2, Brandon Mistretta3, Dinakar Iyer3, Liheng Shi4, Preethi H. Gunaratne3, Gladys Ko4,…

Scientists at Texas Biomed establish a human transgenic mouse model susceptible to SARS-CoV-2 infection

Study provides research community with critical small animal model necessary for researchers developing therapies and…

Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation

This research was supported in part by the Robert J. Kleberg, Jr. and Helen C.…